CMS has presented for publication in the Federal Register a new proposed rule on changes to the ESRD PPS/QIP. Public Comment must be received by September 4, 2020. “In addition to the annual technical updates for the ESRD PPS, the proposed rule proposes the following:
- “An addition to the ESRD PPS base rate to include calcimimetics in the ESRD PPS bundled payment;
- “Changes to the eligibility criteria and determination process for the transitional add-on payment adjustment for new and innovative equipment and supplies (TPNIES);
- “The expansion of the TPNIES to include new and innovative capital-related assets that are home dialysis machines;
- “A change to the low-volume adjustment eligibility criteria and attestation requirement to account for the COVID-19 PHE;
- “An update to the ESRD PPS wage index to adopt the new OMB delineations with a transition period. …
- “The following updates to the ESRD QIP:
- “Scoring methodology changes to the UFR reporting measure;
- “Updates to the NHSN validation study.”
- “This proposed rule also provides information received from two manufacturers whose products, a dialyzer and a cartridge for a home dialysis machine, are being considered for TPNIES in CY 2021.”
The (slightly edited) quotations are from the ESRD PPS CY2021 Proposed Rule Fact Sheet (CMS-1732-P) at https://www.cms.gov/newsroom/fact-sheets/end-stage-renal-disease-esrd-prospective-payment-system-pps-calendar-year-cy-2021-proposed-rule-cms. Find the Federal Register entry, which is scheduled to be published on July 13, 2020, at https://www.federalregister.gov/documents/2020/07/13/2020-14671/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis.
